These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14673570)

  • 21. HLA compatibility index: does it have a role in patients after heart transplantation?
    Bedanova H; Orban M; Ondrasek J; Stepanova R; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):5-11. PubMed ID: 23446213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.
    Böhringer D; Reinhard T; Duquesnoy RJ; Böhringer S; Enczmann J; Lange P; Claas F; Sundmacher R
    Transplantation; 2004 Feb; 77(3):417-21. PubMed ID: 14966417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival.
    Rudolph EN; Dunn TB; Mauer D; Noreen H; Sutherland DE; Kandaswamy R; Finger EB
    Am J Transplant; 2016 Aug; 16(8):2401-12. PubMed ID: 26814363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
    De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
    Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matching for Human Leukocyte Antigens (HLA) in corneal transplantation - to do or not to do.
    van Essen TH; Roelen DL; Williams KA; Jager MJ
    Prog Retin Eye Res; 2015 May; 46():84-110. PubMed ID: 25601193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rejection following corneal transplantation. Effect of HLA compatibility of the grafts].
    Boisjoly HM; Dubé I; Laughrea PA; Roy R; Bernard PM
    Clin Invest Med; 1989 Aug; 12(4):221-3. PubMed ID: 2535434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative effect of HLA-DR matching on corneal transplant rejection.
    Bradley BA; Vail A; Gore SM; Rogers CA; Armitage WJ; Nicholls S; Easty DL
    Transplant Proc; 1995 Feb; 27(1):1392-4. PubMed ID: 7878924
    [No Abstract]   [Full Text] [Related]  

  • 30. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplasty.
    Armitage WJ; Winton HL; Jones MNA; Downward L; Crewe JM; Rogers CA; Tole DM; Dick AD
    Br J Ophthalmol; 2022 Jan; 106(1):42-46. PubMed ID: 33268345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.
    Lardy NM; van der Horst AR; ten Berge IJ; Surachno S; Wilmink JM; de Waal LP
    Transplantation; 1997 Aug; 64(4):612-6. PubMed ID: 9293875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
    Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
    Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histocompatibility Y antigen compatibility and allograft rejection in corneal transplantation.
    Inoue K; Amano S; Oshika T; Tsuru T
    Eye (Lond); 2000 Apr; 14 ( Pt 2)():201-5. PubMed ID: 10845017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.